Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on May 6, 2025

Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer

Mersana Therapeutics Announces Strategic Restructuring and Reprioritization Plan Focused on Advancing Emi-Le in Triple-Negative Breast Cancer

Cost-saving initiatives expected to extend company’s cash runway and support current operating plan commitments into mid-2026 Company to host conference call at 8:00 a.m. ET on May 15 to discuss business updates and first quarter 2025 financial results …

Topas Therapeutics’ TPM502 Achieves Gluten-specific Tolerance Induction, Positive Safety Profile in Phase 2a Trial in Celiac Disease Patients

Topas Therapeutics’ TPM502 Achieves Gluten-specific Tolerance Induction, Positive Safety Profile in Phase 2a Trial in Celiac Disease Patients

TPM502 achieved significant and dose-dependent reduction in IL-2 and IFN-γ release by gluten-specific T cells and durable immunomodulation of gluten-specific CD4+ T cells Patient-reported outcomes indicated dose-dependent reduction of symptoms following a …

Optima Health to acquire Care first

Optima Health to acquire Care first

Optima Health to acquire Care first, a leading provider of mental health services, for a net consideration of £15,000, adding c.£3.7 million revenue to the Group Acquisition provides Optima with increased scale in its Mental Health division and will …

EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025

EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025

EnteroBiotix Presents Positive IBS-C Data at Digestive Disease Week® 2025 EBX-102-02 was well tolerated and demonstrated clinically meaningful improvements across multiple symptom domains in IBS-C patients Ph2b trial in IBS-C initiating in H2 2025 to …

MADD Canada’s Campaign 911 Urges People to Report Suspected Impaired Drivers, Riders and Boaters

MADD Canada’s Campaign 911 Urges People to Report Suspected Impaired Drivers, Riders and Boaters

OAKVILLE, Ontario, May 06, 2025 (GLOBE NEWSWIRE) -- An impaired driver is an emergency. That’s the powerful message at the heart of MADD Canada’s Campaign 911, the national awareness program launching today to encourage Canadians to call 911 and report …

La Campagne 911 de MADD Canada exhorte les gens à signaler les conducteurs d’auto, de VTT et de bateau dont les capacités semblent affaiblies

La Campagne 911 de MADD Canada exhorte les gens à signaler les conducteurs d’auto, de VTT et de bateau dont les capacités semblent affaiblies

OAKVILLE, Ontario, 06 mai 2025 (GLOBE NEWSWIRE) -- Les conducteurs aux capacités affaiblies sont des situations d’urgence. C’est le puissant message au cœur de la Campagne 911 de MADD Canada, le programme de sensibilisation nationale, lancé aujourd’hui …

Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference

Fractyl Health to Report First Quarter 2025 Financial Results and Provide Business Updates on May 13, 2025, and Will Participate in an Upcoming Investor Conference

BURLINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the “Company”), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced it …

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

Apellis Pharmaceuticals to Present at Upcoming Investor Conferences

WALTHAM, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will participate in the following May investor conferences: BofA Securities 2025 Healthcare Conference: Fireside chat on Tuesday, …

Blue Point Brewing Co. Announces the Return of Delayed Pilsner

Blue Point Brewing Co. Announces the Return of Delayed Pilsner

PATCHOGUE, N.Y., May 06, 2025 (GLOBE NEWSWIRE) -- Blue Point Brewing Co., a Tilray Brands, Inc., (NASDAQ: TLRY and TSX: TLRY) craft beer brand, announces the highly anticipated re-release of Delayed Pilsner, a beer crafted to soothe the soul of every New …

TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

TScan Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Updates from the PLEXI-T™ solid tumor and ALLOHA™ heme Phase 1 clinical trials anticipated by end of year On-track to file IND application for TSC-102-A0301 (CD45; HLA-A*03:01) to FDA in the second half of the year Appointed commercial leader Stephen …

Vantage Hemp Co. Submits Application for Brazil Market Entry

Vantage Hemp Co. Submits Application for Brazil Market Entry

Greeley, Colorado, May 06, 2025 (GLOBE NEWSWIRE) -- Vantage Hemp Co. (“Vantage” or “the Company”), a globally accredited cannabinoid extractor and manufacturer, has initiated its regulatory process with ANVISA, Brazil’s National Health Surveillance Agency, …

Transpire Bio Announces R&D and Manufacturing Expansion

Transpire Bio Announces R&D and Manufacturing Expansion

SUNRISE, Fla., May 06, 2025 (GLOBE NEWSWIRE) -- Transpire Bio, an integrated clinical-stage biopharmaceutical company focused on developing inhaled therapeutics for pulmonary and systemic diseases, today announced that it has signed an agreement to expand …

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

Upstream Bio Reports First Quarter 2025 Financial Results and Accelerates Guidance on All Clinical Programs

– Top-line data from Phase 2 clinical trial of verekitug in patients with chronic rhinosinusitis with nasal polyps expected in the third quarter of 2025 – – Top-line data from Phase 2 clinical trial of verekitug in patients with severe asthma now expected …

Advanced Aesthetics Plastic Surgery Partners with Ascend Aesthetic Partners to Strengthen a Collaborative Community Focused on Growth, Learning, and Patient Care

Advanced Aesthetics Plastic Surgery Partners with Ascend Aesthetic Partners to Strengthen a Collaborative Community Focused on Growth, Learning, and Patient Care

ATLANTA, May 06, 2025 (GLOBE NEWSWIRE) -- Advanced Aesthetics Plastic Surgery has joined Ascend Aesthetic Partners, forming a partnership rooted in shared values of collaboration, clinical excellence, and continuous learning. With the addition of Dr. …

Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis

Tiziana Life Sciences Announces Comprehensive Positive Results from Study of Nasal Foralumab in Patients with Multiple Sclerosis

Meaningful Fatigue score reduction seen in study is a critically important quality of life (QoL) measure for Multiple Sclerosis patients. All patients experienced stabilization of Expanded Disability Status Scale (EDSS) scores. TSPO-PET imaging showed …

Sharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ Syringes

Sharps Technology Receives ~$100K Initial Purchase Order from Hungarian Vaccine Provider for SecureGard™ Syringes

Sharps also received an initial qualification purchase order for DisGard™ single-use Sharps Recovery System Company transitions to revenue producing with second purchase order, bringing total recent orders to approximately $500,000 for the quarter NEW YORK …

Slimjaro Under Review : Inspecting the Results of Slim jaro ingredients, Benefits, Pros and Cons! Pink Salt Trick Recipe for Weight Loss

Slimjaro Under Review : Inspecting the Results of Slim jaro ingredients, Benefits, Pros and Cons! Pink Salt Trick Recipe for Weight Loss

Kansas City MO, May 06, 2025 (GLOBE NEWSWIRE) -- Let's face it - we're drowning in weight loss products that promise the world but leave us high and dry. But there's a new kid on the block called Slimjaro, and it's got doctors, researchers, and real people …

Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025

Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025

Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of PDE3 and PDE4 for a broad COPD population LONDON and RALEIGH, N.C., May 06, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona” or the “Company”), a …

CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE

CYCLACEL PHARMACEUTICALS, INC. ANNOUNCES EXECUTION OF SHARE EXCHANGE AGREEMENT TO MAKE FITTERS SDN. BHD. ITS WHOLLY-OWNED SUBSIDIARY TO ACCELERATE GROWTH AND STOCKHOLDER VALUE

KUALA LUMPUR, MALAYSIA, May 06, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; “Cyclacel” or the “Company”) today announced that it entered into an Exchange Agreement with FITTERS Diversified Berhad (9318.KL; “FITTERS …

The 4 Best Male Enhancement Pills to Buy OTC, In Stores & Online 2025: Top Sex Pills for Men's Sexual Performance Over the Counter - Leading Edge Health

The 4 Best Male Enhancement Pills to Buy OTC, In Stores & Online 2025: Top Sex Pills for Men's Sexual Performance Over the Counter - Leading Edge Health

Limassol, Cyprus, May 06, 2025 (GLOBE NEWSWIRE) -- The top male enhancement pills for 2025 is presented by Leading Edge Health Finding the best male enhancement pill can feel overwhelming with so many options available over the counter, in stores, and …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service